Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.

Sunkaraneni S, Ludwig EA, Passarell JA, Blum D, Grinnell T, Fiedler-Kelly J.

J Clin Pharmacol. 2018 Jul;58(7):927-938. doi: 10.1002/jcph.1086. Epub 2018 Mar 12.

PMID:
29528499
2.

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy.

Sunkaraneni S, Passarell JA, Ludwig EA, Fiedler-Kelly J, Pitner JK, Grinnell TA, Blum D.

Clin Pharmacol. 2017 Jun 27;9:65-72. doi: 10.2147/CPAA.S133815. eCollection 2017.

3.

Pharmacokinetics of Tedizolid in Obese and Nonobese Subjects.

Flanagan S, Minassian SL, Passarell JA, Fiedler-Kelly J, Prokocimer P.

J Clin Pharmacol. 2017 Oct;57(10):1290-1294. doi: 10.1002/jcph.928. Epub 2017 May 16. No abstract available.

PMID:
28510339
4.

Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.

Hopkins SC, Sunkaraneni S, Skende E, Hing J, Passarell JA, Loebel A, Koblan KS.

Clin Drug Investig. 2016 Feb;36(2):137-46. doi: 10.1007/s40261-015-0358-7.

5.

Bendamustine pharmacokinetic profile and exposure-response relationships in patients with indolent non-Hodgkin's lymphoma.

Owen JS, Melhem M, Passarell JA, D'Andrea D, Darwish M, Kahl B.

Cancer Chemother Pharmacol. 2010 Nov;66(6):1039-49. doi: 10.1007/s00280-010-1254-8. Epub 2010 Feb 6.

6.

Application of patient population-derived pharmacokinetic-pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci.

Ambrose PG, Meagher AK, Passarell JA, Van Wart SA, Cirincione BB, Bhavnani SM, Ellis-Grosse E.

Diagn Microbiol Infect Dis. 2009 Feb;63(2):155-9. doi: 10.1016/j.diagmicrobio.2008.10.011.

PMID:
19150707
7.

Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints.

Ambrose PG, Meagher AK, Passarell JA, Van Wart SA, Cirincione BB, Rubino CM, Korth-Bradley JM, Babinchak T, Ellis-Grosse E.

Diagn Microbiol Infect Dis. 2009 Jan;63(1):38-42. doi: 10.1016/j.diagmicrobio.2008.09.014.

PMID:
19073300
8.

Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections.

Passarell JA, Meagher AK, Liolios K, Cirincione BB, Van Wart SA, Babinchak T, Ellis-Grosse EJ, Ambrose PG.

Antimicrob Agents Chemother. 2008 Jan;52(1):204-10. Epub 2007 Oct 22.

9.

Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment.

Fetterly GJ, Owen JS, Stuyckens K, Passarell JA, Zannikos P, Soto-Matos A, Izquierdo MA, Perez-Ruixo JJ.

Cancer Chemother Pharmacol. 2008 Jun;62(1):135-47. Epub 2007 Oct 9.

PMID:
17922277
10.

Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections.

Meagher AK, Passarell JA, Cirincione BB, Van Wart SA, Liolios K, Babinchak T, Ellis-Grosse EJ, Ambrose PG.

Antimicrob Agents Chemother. 2007 Jun;51(6):1939-45. Epub 2007 Mar 12.

11.

Pharmacokinetic-pharmacodynamic relationships describing the efficacy of oritavancin in patients with Staphylococcus aureus bacteremia.

Bhavnani SM, Passarell JA, Owen JS, Loutit JS, Porter SB, Ambrose PG.

Antimicrob Agents Chemother. 2006 Mar;50(3):994-1000.

12.

Challenges in the transition to model-based development.

Grasela TH, Fiedler-Kelly J, Walawander CA, Owen JS, Cirincione BB, Reitz KE, Ludwig EA, Passarell JA, Dement CW.

AAPS J. 2005 Oct 5;7(2):E488-95. Review.

13.

Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.

Duerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES, Constine LS, Raubertas RF, Passarell JA, DiPersio JF.

Bone Marrow Transplant. 2000 Mar;25(5):489-94.

Supplemental Content

Loading ...
Support Center